Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tata Capital Private Equity is the private equity arm of Tata Capital, a subsidiary of the global Tata Group conglomerate. The firm manages several specialized funds, most notably the Tata Capital Healthcare Fund (TCHF), which focuses on growth-stage investments across the healthcare and life sciences value chain. Their investment strategy targets sectors such as pharmaceuticals, medical devices, healthcare services, and diagnostics, primarily within the Indian market and companies with significant Indian operations. By providing strategic capital and leveraging the Tata brand, the firm helps portfolio companies scale their operations, improve clinical delivery, and expand into international markets. Notable investments include companies in the contract research and manufacturing services (CRAMS) and specialized pharmaceutical formulations sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tata Capital Private Equity.